Mirae Asset Global Investments Co., Ltd. Vera Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,110 shares of VERA stock, worth $75,917. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,110
Previous 1,983
6.4%
Holding current value
$75,917
Previous $87,000
2.3%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VERA
# of Institutions
185Shares Held
55.6MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$155 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$142 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$120 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$107 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$101 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $973M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...